This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Traditionally, a university degree has been seen as the golden ticket to career success. But there is a growing trend towards skills-based hiring , with more emphasis on the specific abilities a candidate can demonstrate rather than the diplomas they hold. But is this shift the future of hiring or just another fleeting trend?
The emergence of multi-access edge computing (MEC) is transforming the global telecommunications landscape by decentralizing infrastructure, and bringing advanced intelligence, processing, analytics, and communications closer to network endpoints and gateways. This shift is enabling real-time insights and responses, facilitating seamless service delivery, optimized network operations, and enhanced user experience, especially for mission-critical and latency-sensitive applications.
Life sciences companies are revolutionizing the management of cardiometabolic diseases through the integration of omics-based research, advanced therapies, and digital health solutions. This convergence has paved the way for innovative approaches that not only enhance patient outcomes but also reduce healthcare utilization and hospital readmissions.
The landscape of immune-oncology (I-O) is rapidly evolving, driven by groundbreaking innovations in cell therapies and immune checkpoint inhibitors (ICIs). As the leading class of I-O agents, ICIs continue to be a foundational treatment for various cancers, while emerging therapies like Chimeric Antigen Receptor T (CAR-T) and Natural Killer (NK) cells are offering new avenues for targeted and more effective treatments.
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 61,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content